1,348
Views
29
CrossRef citations to date
0
Altmetric
Estradiol Therapy and Breast Cancer Risk

Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis

, , , , &
Pages 87-92 | Received 14 Sep 2016, Accepted 12 Oct 2016, Published online: 29 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Saira J Khan, Ekta Kapoor, Stephanie S Faubion & Juliana M Kling. (2023) Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives. International Journal of Women's Health 15, pages 273-287.
Read now
Shelli Graham, David F. Archer, James A. Simon, Kathleen M. Ohleth & Brian Bernick. (2022) Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins. Gynecological Endocrinology 38:11, pages 891-910.
Read now
D. A. Tan & A. R. B. Dayu. (2022) Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk. Climacteric 25:4, pages 362-368.
Read now
David F. Archer, Brian A. Bernick & Sebastian Mirkin. (2019) A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause. Expert Review of Clinical Pharmacology 12:8, pages 729-739.
Read now
S. Mirkin. (2018) Evidence on the use of progesterone in menopausal hormone therapy. Climacteric 21:4, pages 346-354.
Read now
P. Stute, L. Wildt & J. Neulen. (2018) The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 21:2, pages 111-122.
Read now

Articles from other publishers (23)

Meijun Pan, Jing Zhou, Xinyao Pan, Jing Wang, Qing Qi & Ling Wang. (2023) Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy. Life Sciences 312, pages 121255.
Crossref
Julia J. Segura-Uribe, Paola García-de la Torre, Tzayaka Castillo-Mendieta, Iván Bribiesca-Cruz, Sandra Orozco-Suárez, Marvin A. Soriano-Ursúa, Rodolfo Pinto-Almazán, Claudia E. Fuentes-Venado & Christian Guerra-Araiza. (2022) Tibolone Improves Memory and Decreases the Content of Amyloid-β Peptides and Tau Protein in the Hippocampus of a Murine Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 90:4, pages 1437-1447.
Crossref
Song Gao, Rongjin Sun, Rashim Singh, Sik Yu So, Clement T.Y. Chan, Tor Savidge & Ming Hu. (2022) The role of gut microbial β-glucuronidase in drug disposition and development. Drug Discovery Today 27:10, pages 103316.
Crossref
JoAnn V. Pinkerton, Carolyn S. Wilson & Andrew M. Kaunitz. (2022) Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer. Menopause 29:9, pages 1001-1004.
Crossref
O.О. Yefimenko. (2022) Menopauseal hormonal therapy and the risk of breast cancer in the light of new data. REPRODUCTIVE ENDOCRINOLOGY:66, pages 77-80.
Crossref
Bonnie Liang, Ada S. Cheung & Brendan J. Nolan. (2022) Clinical features and prevalence of Klinefelter syndrome in transgender individuals: A systematic review. Clinical Endocrinology 97:1, pages 3-12.
Crossref
Haim A. Abenhaim, Samy Suissa, Laurent Azoulay, Andrea R. Spence, Nicholas Czuzoj-Shulman & Togas Tulandi. (2022) Menopausal Hormone Therapy Formulation and Breast Cancer Risk. Obstetrics & Gynecology 139:6, pages 1103-1110.
Crossref
Maria Alejandra Belardo, Pisula Pedro & Capalbo Olivia. (2022) Breast cancer and progestins in menopausal hormone therapy: a literature review. Obstetrics & Gynecology International Journal 13:2, pages 101-110.
Crossref
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment 27 45 .
Qingyun Zheng, Thomas Kernozek, Adam Daoud-Gray & Katarina T. Borer. (2021) Anabolic Bone Stimulus Requires a Pre-Exercise Meal and 45-Minute Walking Impulse of Suprathreshold Speed-Enhanced Momentum to Prevent or Mitigate Postmenopausal Osteoporosis within Circadian Constraints. Nutrients 13:11, pages 3727.
Crossref
Marià Alemany. (2021) Estrogens and the regulation of glucose metabolism. World Journal of Diabetes 12:10, pages 1622-1654.
Crossref
Ursula Gobrecht-Keller. (2021) Gestagengabe in der Menopause: Was sind Unterschiede, Vorteile und Nachteile der einzelnen Präparate?Administration de progestatifs dans la ménopause: différences, avantages et inconvénients des différentes préparations. Journal für Gynäkologische Endokrinologie/Schweiz 24:2, pages 58-68.
Crossref
Johanna Becker & Nina Rogenhofer. (2021) Hormontherapie im Klimakterium - Fluch oder Segen?Hormonal Therapy - Curse or Blessing. MMW - Fortschritte der Medizin 163:4, pages 52-61.
Crossref
Moamen M. Elmassry, Sunghwan Kim & Ben Busby. (2021) Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes. PLOS ONE 16:1, pages e0244876.
Crossref
James H. Liu, Denise R. Black, Lisa Larkin, Shelli GrahamBrian BernickSebastian Mirkin. (2020) Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial. Menopause 27:12, pages 1388-1395.
Crossref
Jo Marsden & Hugo Pedder. (2020) The risks and benefits of hormone replacement therapy before and after a breast cancer diagnosis. Post Reproductive Health 26:3, pages 126-135.
Crossref
Jo Marsden, Hugo Pedder & Richard Santen. (2020) WITHDRAWN – Administrative Duplicate Publication: Risks and benefits of hormone replacement therapy before and after a breast cancer diagnosis. Post Reproductive Health, pages 205336912093402.
Crossref
Katrine Yare & Michael Woodward. (2020) Hormone Therapy and Effects on Sporadic Alzheimer’s Disease in Postmenopausal Women: Importance of Nomenclature. Journal of Alzheimer's Disease 73:1, pages 23-37.
Crossref
Benjamin S. Harris, Katherine C. Bishop, Jeffrey A. Kuller, Anne C. Ford, Lisa C. Muasher, Sarah E. Cantrell & Thomas M. Price. (2020) Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy. Menopause 27:2, pages 243-248.
Crossref
Jan J. Stepan, Hana Hruskova & Miloslav Kverka. (2019) Update on Menopausal Hormone Therapy for Fracture Prevention. Current Osteoporosis Reports 17:6, pages 465-473.
Crossref
Balasunder R. Dodda, Corry D. Bondi, Mahmud Hasan, William P. Clafshenkel, Katie M. Gallagher, Mary P. Kotlarczyk, Shalini Sethi, Ethan Buszko, Jean J. Latimer, J. Mark Cline, Paula A. Witt-Enderby & Vicki L. Davis. (2019) Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. Frontiers in Oncology 9.
Crossref
Mélanie Bourque, Marc Morissette & Thérèse Di Paolo. (2019) Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease. Neuropharmacology 147, pages 37-54.
Crossref
Genevieve Victoria Dall & Kara Louise Britt. (2017) Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk. Frontiers in Oncology 7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.